Epidemiologic, genetic, pathogenic, metabolic, epigenetic aspects involved in NASH-HCC: current therapeutic strategies

J Gutiérrez-Cuevas, S Lucano-Landeros… - Cancers, 2022 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is an aggressive human cancer and is
caused as consequences of chronic liver diseases. Although HCC is more common in …

Addressing racial and ethnic disparities in US liver cancer care

NJ Kim, A Cravero, T VoPham, P Vutien… - Hepatology …, 2023 - journals.lww.com
HCC, the most common form of primary liver cancer, is the fastest rising cause of cancer-
related death in the United States. HCC disproportionately affects racial and ethnic …

Increasing risk of hepatocellular carcinoma with successive generations in the United States among Mexican American adults: The Multiethnic Cohort

N Acuna, K Zhou, PS Pinheiro, I Cheng… - Cancer, 2024 - Wiley Online Library
Background US‐born Latinos have a higher incidence of hepatocellular carcinoma (HCC)
than foreign‐born Latinos. Acculturation to unhealthy lifestyle behaviors and an immigrant …

Cancer‐related knowledge, beliefs, and behaviors among Hispanic/Latino residents of Indiana

MR Espinoza‐Gutarra, SM Rawl, G Maupome… - Cancer …, 2023 - Wiley Online Library
Background Cancer is the leading cause of death for Hispanics in the USA. Screening and
prevention reduce cancer morbidity and mortality. Methods This study administered a cross …

Racial disparities in clinical presentation, surgical procedures, and hospital outcomes among patients with hepatocellular carcinoma in the United States

L Chikovsky, T Kutuk, M Rubens, AN Balda, H Appel… - Cancer …, 2023 - Elsevier
Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related
deaths in the United States (US), with substantial disparities observed in cancer incidence …

[HTML][HTML] Ethnic disparities in the epidemiology, treatment, and outcome of patients with hepatocellular carcinoma in the United States

MS Rezaee-Zavareh, J Liang, JD Yang - Hepatoma research, 2023 - ncbi.nlm.nih.gov
There are significant ethnic disparities in incidence, tumor stage, curative therapy receipt,
and survival among patients with hepatocellular carcinoma (HCC) in the US. While previous …

Assessing Physicians' Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and …

TF Begum, VS Patil, L Zhu, MC Yeh, E González… - Journal of Community …, 2024 - Springer
Deaths from liver cancer are on the rise and disproportionately affect minority racial/ethnic
groups. In this study, we examined associations between physicians' recommendations for …

Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?

M Ahmad, A Dhasmana, PS Harne, A Zamir… - Seminars in Cancer …, 2022 - Elsevier
Tumor heterogeneity is a predominant feature of hepatocellular carcinoma (HCC) that plays
a crucial role in chemoresistance and limits the efficacy of available chemo/immunotherapy …

[HTML][HTML] Disparities in hepatocellular carcinoma incidence among Hispanic and non-Hispanic adults in Arizona: Trends between 2009-2017

KE Morrill, P Wightman, A Cruz, K Batai, GD Block… - Annals of …, 2024 - Elsevier
Background Hepatocellular carcinoma (HCC) is a highly lethal cancer with few treatment
options available to patients. Most HCC cases in Arizona, a state with a high proportion of …

Impacts of neighborhood characteristics and surgical treatment disparities on overall mortality in stage I renal cell carcinoma patients

A Cruz, F Dickerson, KR Pulling, K Garcia… - International Journal of …, 2022 - mdpi.com
Racial/ethnic minority groups in the United States have high renal cell carcinoma (RCC)
mortality rates. This study assessed surgical treatment disparities across racial/ethnic groups …